The objective of this study was to develop European League Against Rheumatism/American
College of Rheumatology classification criteria for polymyalgia rheumatica (PMR). …

Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international
recommendations for PMR treatment are not currently available. In this paper, we report the …

OBJECTIVE: Hormone replacement therapy (HRT) is known to exert a positive effect in
preventing bone loss and a beneficial effect on the disease activity in rheumatoid arthritis (RA). …

Although giant cell arteritis affects the arteries,'the statistical survival rate in several studies
has been shown to be the same as that of the general popula-tion. 2'These series have been …

Objective: To assess female sex hormone related variables in a group of women with biopsy
positive giant cell arteritis and a control group. Methods: 49 women with biopsy positive …

Objective. To prospectively evaluate the disease course and the performance of clinical,
patient-reported outcome (PRO) and musculoskeletal ultrasound measures in patients with …

Hormone replacement therapy (HRT) modulates the imbalance in bone remodeling, thereby
decreasing bone loss. Sex hormones are known to influence rheumatic diseases. The aim …

Giant cell arteritis (GCA) or temporal arteritis (TA) is a chronic vasculitis of large and medium-size
arteries. Symptomatic vessel inflammation preferentially involves the aorta and its …

The first description of giant cell arteritis (GCA) as a systemic arteritic disease of the large
and medium-sized arteries was made by Gilmour in 1941. 31 He reported the histologic …

Sixty three patients (51 women, 12 men) with giant cell arteritis were studied by serial
analyses of von Willebrand factor antigen (vWF: Ag) concentration and plasminogen activator …